Library
5-AEDB
Practically no human research exists; all parameters are based on scattered user reports of 5-AEDB sold online between 2019-2024 and extrapolation from related benzofurans (5-APB, 5-APDB). Potency appears roughly 60-70% of 5-APB by weight and markedly shorter in duration. Users frequently report pronounced peripheral stimulation (increased heart rate and blood pressure) compared with MDMA, alongside moderate empathogenic warmth and mild visual enhancement. Severe vasoconstriction, bruxism, and nystagmus have been described at doses above 100 mg. Because reagent reactions overlap with 5-APDB and other APBs, professional analysis (FT-IR/GC-MS) is recommended.
Classification
- Chemical: Benzofuran
- Chemical: Phenethylamine
- Psychoactive: Entactogen
- Psychoactive: Psychedelic
- Psychoactive: Stimulant
- Tag: Research-Chemical
Effects
- Anxiolysis
- Stimulation
- Teeth Grinding
- Vasoconstriction
- Pupil Dilation
- Difficulty Sleeping
- Euphoria
- Empathy And Prosocial Feelings
- Talkativeness
- Alertness Enhancement
- Time Distortion
- Confusion
- Tactile Enhancement
- Visual Tracers
- Light Sensitivity
- Open Eye Visuals
- Tracers
- Color Enhancement
Routes of Administration
Oral
Dosage
- Threshold: 25 mg
- Light: 40-60 mg
- Common: 60-100 mg
- Strong: 100-130 mg
- Heavy: 130 mg
Duration
- Onset: 0.75-1.5 h
- Comeup: 0.5-1 h
- Peak: 1.5-3 h
- Offset: 1-2 h
- After Effects: 2-6 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
